Updated December 13, 2022.
For a 10mg vial providing 5 doses at 2mg each, dead space losses of approximately 1 unit per draw mean roughly 5 units (50mcg at 10mg/mL) lost total
Companies are competing to offer treatments that provide: Strong weight-loss results Favorable safety profiles Convenient dosing Broad patient appeal Industry Impact Pharmaceutical Companies: The development intensifies competition within the rapidly expanding obesity-treatment market
Semaglutide (Wegovy) carries a list price exceeding $1,300 per month
At the lower doses used for diabetes, they have somewhat lower rates of diarrhea (9-12% for Ozempic, 12-21% for Mounjaro) compared to their weight management counterparts
Ta pauser, fr en enkel oversikt over spilling og budsjett, og vr oppmerksom p tegn p impulsiv atferd